https://www.thebodypro.com/tag/news-analysis

News Analysis

The Latest

doctor getting ready to give patient vaccine

HIV Vaccine Trial Stopped Early, but Research Into Other Approaches Continues

HVTN 702 is but one of many vaccine trials underway, researchers note.

Undetectable = Untransmittable -- CATIE Signs On Img

Factors Associated With Hepatitis C Infection Among Men Who Take PrEP

IPERGAY scientists recommended that clinicians screen patients who request PrEP, as well as patients who are already using it, for a number of key HCV risk factors.

woman from behind with arms crossed over head

Barriers to Cisgender Women and HIV Prevention

Health care providers and educators need to acknowledge the impact of clinical bias and reframe sexual health education when it comes to tending to cisgender women's needs, Chase Alston writes.

Senior woman receives prescription medication from doctor

Should All PrEP Users on Truvada Switch to Descovy? These Leading Docs Say, ‘Not So Fast.’

Many fear the push to put more people on the new brand-name drug before Truvada goes generic this year.

syringe going into vial

FDA Rejects Injectable HIV Treatment, but Not Due to Drug Safety

This may be a temporary setback, but long-acting antiretroviral therapy is still on the way, experts say.

U.S. Border Agents Patrol The Rio Grande Valley In Texas

We Must End HIV-Based Family Separation at the Border

In this op-ed, a group of family physicians and HIV specialists revisit the cruel reality happening at the U.S. border for people living with HIV.

Facebook logo reflected in an eye

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Pre-exposure prophylaxis (PrEP) is a vital part of ending HIV, but ads targeting people to join lawsuits are planting needless fears in patients, three leading HIV specialists write.

Customer giving medical prescription to pharmacist

What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription

Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.

close up of man's arm getting blood drawn

We Have a Cure for Hepatitis C. Why Are Rates So High?

An in-depth update on what we know about HCV risk, symptoms, screening, outcomes, and treatment (including financial barriers).

Washington DC at sunset, including Washington Monument

IDWeek 2019: What to Expect at This Year's Conference

We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.